Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome

International Journal of Dermatology

Volumn 46, Issue 12, 2007, Pages 1263-1266

  Ziyaeyan, Mazyar ^a   Alborzi, Abdolvahab ^a   Japoni, Aziz ^a   Kadivar, Mohammad ^a   Davarpanah, Mohammad Ali ^a   Pourabbas, Bahman ^a   Abassian, Amin ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADOLESCENT; ADULT; AIDS PATIENT; ANTIBIOTIC RESISTANCE; ARTICLE; CONCENTRATION RESPONSE; DRUG SENSITIVITY; FEMALE; HERPES; HERPES SIMPLEX VIRUS; HUMAN; IC 50; IMMUNOCOMPETENCE; MALE; NONHUMAN; PREVALENCE; SUPERINFECTION; VIRUS ISOLATION; VIRUS RESISTANCE; VIRUS STRAIN;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACYCLOVIR; ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CHILD; DRUG RESISTANCE, VIRAL; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; IMMUNOCOMPETENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; VERO CELLS;

EID: 37549046794     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03449.x     Document Type: Article

References (23)

1. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet 2001; 357: 1513-1518.
2. Bacon TH, Levin MJ, Leary JJ, et al. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003; 16: 114-128.
3. Gilbert C, Bestman-Smith J, Boivin G. Resistance of herpesviruses to antiviral drugs: Clinical impacts and molecular mechanisms. Drug Resist Update 2002; 5: 88-114.
4. Stranska R, Schuurman R, Nienhuis E, et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: Prevalence and characterization. J Clin Virol 2005; 32: 7-18.
5. Shin YK, Cai GY, Weinberg A, et al. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates. J Clin Microbiol 2001; 39: 913-917.
6. Safrin S, Phan L, Elbeik T. A comparative evaluation of three methods of antiviral susceptibility testing of clinical herpes simplex virus isolates. Clin Diagn Virol 1995; 4: 81-91.
7. Swierkosz EM, Scholl DR, Brown JL, et al. Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrob Agents Chemother 1987; 31: 1465-1469.
8. Hall JD, Coen DM, Fisher BL, et al. Generation of genetic diversity in herpes simplex virus: An antimutator phenotype maps to the DNA polymerase locus. Virology 1984; 132: 26-37.
9. Sarisky RT, Nguyen TT, Duffy KE, et al. Difference in incidence of spontaneous mutations distinct between herpes simplex virus types 1 and 2. Antimicrob Agents Chemother 2000; 44: 1524-1529.
10. Martin JL, Ellis MN, Keller PM, et al. Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother 1985; 28: 181-187.
11. Safrin S, Assaykeen T, Follansbee S, et al. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus infected patients. Antimicrob Agents Chemother 1994; 38: 1246-1250.
12. Sauerbrei A, Eichhorn U, Hottenrott G, et al. Virological diagnosis of herpes simplex encephalitis. J Clin Virol 2000; 17: 31-36.
13. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
14. Chatis PA, Crumpacker CS. Resistance of herpesviruses to antiviral drugs. Antimicrob Agents Chemother 1992; 36: 1589-1595.
15. Parris DS, Harrington JE. Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrob Agents Chemother 1982; 22: 71-77.
16. Collins P, Oliver NM. Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir. J Antimicrob Chemother 1986; 18 (Suppl. B): 103-112.
17. Nugier F, Colin JN, Aymard M, et al. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: Report on a 2-year sensitivity screening survey. J Med Virol 1992; 36: 1-12.
18. Christophers J, Clayton J, Craske J, et al. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother 1998; 42: 868-872.
19. Field HJ. Herpes simplex virus antiviral drug resistance - current trends and future prospects. J Clin Virol 2001; 21: 261-269.
20. Sarisky RT, Crosson P, Cano R, et al. Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility. J Clin Virol 2002; 23: 191-200.
21. Bacon TH, Boon RJ, Schultz M, et al. Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis. Antimicrob Agents Chemother 2002; 46: 3042-3044.
22. Danve-Szatanek C, Aymard M, Thouvenot D, et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004; 42: 24-29.
23. Reyes M, Shaik NS, Graber JM, et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003; 163: 76-80.